Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

ShangPharma to Build $60 Million Biologics Campus

publication date: Sep 17, 2015
ShangPharma, a Shanghai CRO/CMO, will partner with Qidong Biopharma Industrial Zone to build a $60 million biologics campus, including an R&D facility and state-of-the-art manufacturing plant. The two facilities comprise the first stage in a project that is expected to include multiple phases. ShangPharma's CRO division, ChemPartner, will be responsible for the R&D operation while ShangPharma's CMO division, China Gateway Biologics, will be in charge of the commercial scale manufacturing facility. ShangPharma expects the manufacturing plant to be ready for client projects in 2018. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here